Department of Cardiothoracic Surgery, St Thomas' Hospital, London, United Kingdom.
Semin Thorac Cardiovasc Surg. 2012 Autumn;24(3):206-11. doi: 10.1053/j.semtcvs.2012.06.004.
Transcatheter aortic valve implantation (TAVI) is currently used to treat high-risk and inoperable patients with aortic stenosis. The established routes of access are retrograde transfemoral (TF) and antegrade transapical (TA). Transubclavian and transaortic (TAo) routes have been described. We have performed TAo-TAVI with the Edwards Sapien prosthesis (Edwards Lifesciences, Irvine, CA) with the Ascendra I delivery system. From 2010 we have used the Sapien XT prosthesis with the Ascendra II delivery system. In this article we describe in detail the technical aspects of performing TAo TAVI.
经导管主动脉瓣植入术(TAVI)目前用于治疗高危和无法手术的主动脉瓣狭窄患者。已确立的入路途径为逆行股动脉(TF)和顺行经心尖(TA)。已描述了经锁骨下动脉和经主动脉(TAo)途径。我们使用 Edwards Sapien 假体(Edwards Lifesciences,加利福尼亚州欧文)和 Ascendra I 输送系统进行了 TAo-TAVI。自 2010 年以来,我们使用 Sapien XT 假体和 Ascendra II 输送系统。在本文中,我们详细描述了进行 TAo TAVI 的技术方面。